LEP and metabolic dysfunction-associated steatohepatitis: Akinci et al. demonstrated that metreleptin therapy significantly improved NASH scores not only in patients with partial lipodystrophy but also in males with “relative leptin deficiency” (RLD) - defined as leptin levels below the 25th percentile for body mass index and sex based on US population data [10].